Posts in Category: news

Novo Nordisk and United Therapeutics Are the Latest Drug Manufacturers to Limit Access to 340B Prices at Contract Pharmacies

On December 1, 2020, drug manufacturer Novo Nordisk Inc. announced that, effective January 1, 2021, it “will no longer facilitate ‘bill-to/ship-to’ distribution of 340B product

3 Dec 2020

217 Congressional Representatives Send Letter to Secretary Azar Opposing the Kalderos Rebate Model

Thanks to efforts by RWC-340B members and other covered entity advocates, 217 members of the House of Representatives signed a bipartisan letter to Health and

13 Nov 2020

Novartis Takes a Less Restrictive Approach to 340B Pricing at Contract Pharmacies

By letter dated October 30, 2020, Novartis is notifying covered entities that are federal grantees that they will continue to receive 340B discounts at contract

2 Nov 2020

RWC-340B and 340B Grantee Plaintiffs File Lawsuit Against HHS/HRSA to Protect 340B Contract Pharmacy Program from Manufacturer Attacks

On October 9, 2020, RWC-340B and two of its member 340B grantee clinics, Cempa Community Cares and Matthew 25 AIDS Services, Inc., filed a lawsuit

12 Oct 2020

RWC-340B Submits Letter to HHS Regarding Drug Manufacturers Actions That Undermine the 340B Program & Letter to HRSA Regarding 340B Telehealth Policies

Today, RWC-340B submitted to a letter to Secretary of the U.S. Department of Health and Human Services (HHS) Alex Azar requesting that HHS initiate enforcement

11 Sep 2020

Eli Lilly Announces New Limited Distribution Plan

In a notice sent to covered entities and other 340B program participants, Eli Lilly and Co. (Lilly) announced that, effective September 1, 2020, it is

1 Sep 2020

Recap of Second 340B ESP™ Basic User Training Webinar

On August 26, Second Sight Solutions, the owner of the 340B ESP™ platform, hosted the second in a series of webinars on 340B ESP™.  The

28 Aug 2020

RWC-340B Press Statement on Recent Actions Taken by Drug Manufacturers

Here is a press statement from RWC-340B president Shannon Stephenson regarding the recent actions taken by drug manufacturers Lilly, Novartis, Merck, Sanofi, and Astra Zeneca. 

27 Aug 2020

Manufacturers to Provide “340B Rebates” Through New Kalderos Software Platform

This week, Kalderos announced that it is launching its new “340B Pay” platform which, if implemented, would fundamentally change how the 340B drug discount program

27 Aug 2020

Novartis To Collect Contract Pharmacy Claims Data Through 340B ESP, TPAs and Specialty Pharmacies Express Concern Over Data Submitted

Earlier this week a third drug manufacturer, Novartis Pharmaceuticals, sent letters to 340B covered entities with contract pharmacy arrangements stating that beginning October 1, 2020,

20 Aug 2020
Top